# Excella GmbH & Co. KG, Feucht, Germany – FDA Inspections

Source: https://www.keypedia.com/companies/excella-gmbh-co-kg/82bb94ef-8b2e-4e51-8c40-b71a184257f1

> Inspection records and compliance data for Excella GmbH & Co. KG in Feucht. 8 FDA inspections on record, 2 Form 483s, last inspected October 19, 2022.

---

## Details

- Name: Excella GmbH & Co. KG
- FEI Number: 3000242652
- Business Operations: API MANUFACTURE, FDF MANUFACTURE
- Address Line 1: Nurnberger Str. 12
- City: Feucht
- Country Name: Germany
- Address: Nurnberger Str. 12, Feucht, Germany
- Country: Germany

## Related Documents

- [FDA Inspection 1205496 - Excella GmbH & Co. KG - 2022-10-19](https://www.keypedia.com/records/fda_inspections/excella-gmbh-co-kg/b8742aed-0db6-44e0-af06-1b4a0b1a5b62) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 19, 2022
- [FDA Inspection 1098271 - Excella GmbH & Co. KG - 2019-07-12](https://www.keypedia.com/records/fda_inspections/excella-gmbh-co-kg/4ac3f0b8-7ffe-4ca8-847d-71a06c7ee0ce) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 12, 2019
- [FDA Inspection 1064238 - Excella GmbH & Co. KG - 2018-08-10](https://www.keypedia.com/records/fda_inspections/excella-gmbh-co-kg/20fb405a-3bbe-4ad3-9b2e-30067a3b80ee) — source: FDA, date: August 10, 2018
- FDA Inspection 1012240 - Excella GmbH & Co. KG - 2017-03-17 — classification: No Action Indicated (NAI), source: FDA, date: March 17, 2017
- FDA Inspection 1012240 - Excella GmbH & Co. KG - 2017-03-17 — classification: No Action Indicated (NAI), source: FDA, date: March 17, 2017
- FDA Inspection 933855 - Excella GmbH & Co. KG - 2015-05-29 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 29, 2015
- FDA Inspection 933855 - Excella GmbH & Co. KG - 2015-05-29 — classification: No Action Indicated (NAI), source: FDA, date: May 29, 2015
- [FDA Inspection 831974 - Excella GmbH & Co. KG - 2013-05-17](https://www.keypedia.com/records/fda_inspections/excella-gmbh-co-kg/d6a54ce5-0fe9-4001-ba32-977c14744432) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 17, 2013
- FDA Inspection 831974 - Excella GmbH & Co. KG - 2013-05-17 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 17, 2013
- FDA Inspection 806113 - Excella GmbH & Co. KG - 2012-10-10 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 10, 2012

## Related Companies

- [Changzhou Pharmaceutical Factory](https://www.keypedia.com/companies/changzhou-pharmaceutical-factory/eea165e1-3df2-47c8-94b9-e8400af46bc4)
- [Boehringer Ingelheim Pharma GmbH & Co. KG](https://www.keypedia.com/companies/boehringer-ingelheim-pharma-gmbh-co-kg/bcb705bf-98ed-451f-a79d-b6223d2ed263)
- [Xellia Pharmaceuticals ApS](https://www.keypedia.com/companies/xellia-pharmaceuticals-aps/5d9704ca-114e-4a65-abca-966a5c4e2a57)
- [Cohance Lifesciences Limited](https://www.keypedia.com/companies/cohance-lifesciences-limited/c01306bf-33dc-4f28-a424-11cda764a0d5)
- [IDT Australia Ltd.](https://www.keypedia.com/companies/idt-australia-ltd/efc89096-ddbd-47cd-be83-bfa50b1bed16)
- [A. Nelson & Co., Ltd.](https://www.keypedia.com/companies/a-nelson-co-ltd/36fe9f82-7169-47d2-9e57-8ed77942c73d)
- [Cipla Limited](https://www.keypedia.com/companies/cipla-limited/ca77117b-0afe-4b51-bdc2-82ee1e242ec8)
- [Sanofi-Aventis Deutschland GmbH](https://www.keypedia.com/companies/sanofi-aventis-deutschland-gmbh/07c96432-bb43-45e5-a80d-e4bca284dbab)
- [F. Hoffmann - La Roche Ltd.](https://www.keypedia.com/companies/f-hoffmann-la-roche-ltd/622e8fa3-95f3-4ed9-a1bd-99dc0748f273)
- [Cilag AG](https://www.keypedia.com/companies/cilag-ag/acb7f670-89b9-4e40-a784-ed06b0282362)